Mind Medicine (MindMed) (NasdaqGS:MNMD) 2025 Conference November 18, 2025 07:00 AM ET Company ParticipantsNone - Company RepresentativeBrandi Roberts - CFORob Barrow - CEONoneMy name is Michel Fernandez. I'm part of the banking team here at Jefferies. Welcome to this presentation. I'm delighted to host Rob and Brandi, CEO and CFO of MindMed. We'll have a fireside chat. I'll just briefly introduce MindMed. So you're advancing MM120, an orally disintegrating tablet of lysergide in phase III trials for GAD and ...